Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Aliya A. Khan"'
Autor:
Nancy E. Lane, Donald Betah, Cynthia Deignan, Mary Oates, Zhenxun Wang, Jen Timoshanko, Aliya A. Khan, Neil Binkley
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 1, Pp 43-51 (2024)
Objective Romosozumab is a bone‐forming agent approved for osteoporosis treatment. Here we report results of the protocol‐specified, noninferiority osteoarthritis substudy of the fracture study in postmenopausal women with osteoporosis (FRAME), w
Externí odkaz:
https://doaj.org/article/5f62b41b22b6442eac683f398d10d2d2
Publikováno v:
Heliyon, Vol 10, Iss 6, Pp e26928- (2024)
Context: Medical devices fall under the broad topic encompass everything from basic hardware to integrated software systems. The integration of software into hardware devices is not simple due to requirements of regional regulatory bodies. Therefore,
Externí odkaz:
https://doaj.org/article/e13b979a1f4e48439cdd4e4b3071c3b2
Autor:
Dalal S. Ali, Francesca Marini, Farah Alsarraf, Hatim Alalwani, Abdulrahman Alamri, Aliya A. Khan, Maria Luisa Brandi
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Autosomal dominant hypocalcemia (ADH1) is a genetic disorder characterized by low serum calcium and low or inappropriately normal levels of parathyroid hormone. The disease is caused by a heterozygous activating mutation of the calcium-sensing recept
Externí odkaz:
https://doaj.org/article/4ebad02a58434c28816119051fe163e0
Autor:
Steven W. Ing, Richard D. Finkelman, Ping He, Aliya A. Khan, Michael Mannstadt, Lars Rejnmark, Ivy Song, István Takács, Yuna Wu
Publikováno v:
JBMR Plus, Vol 7, Iss 7, Pp n/a-n/a (2023)
ABSTRACT Recombinant human parathyroid hormone (1‐84), rhPTH(1‐84), is an approved adjunctive treatment to oral calcium and active vitamin D for adult patients with hypoparathyroidism; however, there is limited information on the effect of twice
Externí odkaz:
https://doaj.org/article/17a471467fa342a387f2ee7214328b1a
Autor:
Francesca Giusti, Francesca Marini, Hatim Al-alwani, Elena Marasco, Paolo Garagnani, Aliya A. Khan, Maria Luisa Brandi
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 24, p 17289 (2023)
Serum phosphate concentration is regulated by renal phosphate reabsorption and mediated by sodium–phosphate cotransporters. Germline mutations in genes encoding these cotransporters have been associated with clinical phenotypes, variably characteri
Externí odkaz:
https://doaj.org/article/70e90ac10aed4ecd812bd86753b61700
Autor:
Neil Gittoes, Lars Rejnmark, Steven W. Ing, Maria Luisa Brandi, Sigridur Björnsdottir, Stefanie Hahner, Lorenz C. Hofbauer, Pascal Houillier, Aliya A. Khan, Michael A. Levine, Michael Mannstadt, Dolores M. Shoback, Tamara J. Vokes, Pinggao Zhang, Claudio Marelli, John Germak, Bart L. Clarke
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background The PARADIGHM registry of adult and pediatric patients with chronic hypoparathyroidism evaluates the long-term safety and effectiveness of treatment with recombinant human parathyroid hormone, rhPTH(1-84), and describes the clinic
Externí odkaz:
https://doaj.org/article/12c9c84405614bd69518853f175c18a9
Publikováno v:
Osteoporosis and Sarcopenia, Vol 3, Iss 2, Pp 64-74 (2017)
Bisphosphonate (BP)-associated osteonecrosis of the jaw (ONJ) was first reported in oncology patients in 2003 and subsequently in osteoporosis patients in 2004. Since oral surgical procedures, such as tooth extraction, are also considered one of the
Externí odkaz:
https://doaj.org/article/a69e4495fc9d4882998f858725b6cfc0
Autor:
Mona A. Fouda, Aliya A. Khan, Muhammad Sultan, Lorena P. Rios, Karen McAssey, David Armstrong
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2017 (2017)
Externí odkaz:
https://doaj.org/article/522feda06dbf4a9dbf2f054d02bdc8db
Autor:
Aliya A. Khan, Hajar AbuAlrob, Iman M’Hiri, Dalal S. Ali, Karel Dandurand, Hosay Said, Hisham Alkassem, Yasser Hakami, Ismail Hweija, Salman Iqbal, Mihai Romanovschi, Shehryar Mehmood, Heather Zariffeh, Gordon Guyatt, Quazi Ibrahim, Romina Brignardello-Petersen, Hamza I. Syed
Publikováno v:
Endocrine. 80:647-657
Introduction Denosumab is an effective antiresorptive molecule and reduces the risk of fracture in postmenopausal osteoporosis. Cessation of denosumab therapy however is associated with rapid declines in bone mineral density (BMD), rises in bone remo
Autor:
Aliya A. Khan, Hajar AbuAlrob, Hatim Al-alwani, Dalal S. Ali, Khulod Almonaei, Farah Alsarraf, Earl Bogoch, Karel Dandurand, Aaron Gazendam, Angela G. Juby, Wasim Mansoor, Sharon Marr, Emmett Morgante, Frank Myslik, Emil Schemitsch, Prism Schneider, Jenny Thain, Alexandra Papaioannou, Paul Zalzal
Publikováno v:
Osteoporosis International. 34:1011-1035